Cobas C513 Analyzer, Cobas C13 Tina-quant HbA1cDx Gen.3 Assay

Hemoglobin A1c Test System

Roche Diagnostics Operations (RDO)

The following data is part of a premarket notification filed by Roche Diagnostics Operations (rdo) with the FDA for Cobas C513 Analyzer, Cobas C13 Tina-quant Hba1cdx Gen.3 Assay.

Pre-market Notification Details

Device IDK160571
510k NumberK160571
Device Name:Cobas C513 Analyzer, Cobas C13 Tina-quant HbA1cDx Gen.3 Assay
ClassificationHemoglobin A1c Test System
Applicant Roche Diagnostics Operations (RDO) 9115 Hague Road Indianapolis,  IN  46250
ContactDavid Tribbett
CorrespondentDavid Tribbett
Roche Diagnostics Operations (RDO) 9115 Hague Road Indianapolis,  IN  46250
Product CodePDJ  
CFR Regulation Number862.1373 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2016-02-29
Decision Date2016-12-19
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
04015630946327 K160571 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.